Back

5-year outcomes of target all comers randomised trial.

29 August 2022 (12:50 - 13:00)
Organised by:
Congress Presentation Part of: 5-year outcomes of target all comers randomised trial & prospects of target series clinical trials Interventional Cardiology Open Access ESC Congress 2022

About the speaker

Photo
Doctor Alexandra Lansky

Yale School of Medicine, New Haven (United States of America)

7 More presentations in this session

Presentation thumbnail
Opening & target AC project introduction.
Professor A. Baumbach (London, GB)
Slides Video
Presentation thumbnail
Group discussion.
Doctor L. Janssens (Bonheiden, BE) Professor B. Xu (Beijing, CN) Doctor L. Holmvang (Copenhagen, DK) Doctor T. Johnson (Bristol, GB)
Video
Presentation thumbnail
TARGET AC sub-group analysis on diabetics and ACS patients.
Professor N. van Royen (Nijmegen, NL)
Slides Video
Presentation thumbnail
Group discussion.
Doctor L. Holmvang (Copenhagen, DK) Professor B. Xu (Beijing, CN) Doctor T. Johnson (Bristol, GB) Doctor L. Janssens (Bonheiden, BE)
Video
Presentation thumbnail
Prospects of target series clinical trials.
Associate Professor G. Tarantini (Padova, IT)
Slides Video

Access the full session

Session thumbnail
5-year outcomes of target all comers randomised trial & prospects of target series clinical trials
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 12:50 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of target vessel revascularization rates between biodegradable and durable polymer drug-eluting stents: a retrospective study
thumbnail
Congress Presentation
Long-term PCI outcomes in chronic versus acute coronary syndromes: 5-year results of the TARGET All Comers trial
thumbnail
Congress Presentation
Comparison of ridaforolimus-eluting and zotarolimus-eluting coronary stents: 5-Year outcomes from the BIONICS and NIREUS trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources